Bovie Medical (BVX) Misses Q1 EPS by 2c, Miss on Revenues

Bovie Medical (NYSE: BVX) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $8.77 million.

First Quarter 2017 Financial Summary:

• Total Q1 revenue of $8.4 million, up 7.9% year-over-year.
• Domestic Q1 revenue of $7.0 million, up 5.7% year-over-year.
• International Q1 revenue of $1.4 million, up 20.4% year-over-year.
• Net loss of $1.7 million for the three months ended March 31, 2017, compared to a net loss of $1.9 million in the comparable period last year.
• Adjusted EBITDA loss of $1.4 million for the three months ended March 31, 2017, compared to Adjusted EBITDA loss of $1.6 million in the comparable period last year.

For earnings history and earnings-related data on Bovie Medical (BVX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15